EP3482768
Aðferðir og samstæður til að koma í veg fyrir hættu á innrennslismeinsvörun og mótefnis-miðluðu tapi á svörun með því að vakta þvagsýru í blóðvatni við meðferð með PEGýleruðum úríkasa
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
25.6.2010EP published:
28.1.2026EP application number:
18214393.3
EP translation filed:
27.3.2026Grant published:
8.4.2026EPO information:
European Patent Register
Max expiry date:
24.6.2030Expiry date:
24.6.2026
Title in English:
METHODS AND KITS FOR PREVENTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPYLanguage of the patent:
English
Timeline
Today
25.6.2010EP application
28.1.2026EP Publication
27.3.2026Translation submitted
8.4.2026Registration published
24.6.2026Expires
Owner
Name:
Horizon Therapeutics USA, Inc.Address:
1 Horizon Way, Deerfield, Illinois 60015, US
Inventor
Name:
ROSARIO-JANSEN, TheresaAddress:
Randolph, NJ New Jersey 07869, US
Name:
WRIGHT, David, ErickAddress:
Ramona, CA California 92065, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
26966909 PDate:
25.6.2009Country:
US
Number:
29871810 PDate:
27.1.2010Country:
US
Number:
24869809 PDate:
5.10.2009Country:
US
Classification
Categories:
A61K 38/44, G01N 33/53, G01N 33/68, A61K 9/00, A61P 19/02